KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.

Saved in:
Bibliographic Details
Title: KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.
Authors: Yan M; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, P.R. China., Liu K; Department of Research and Education, Tianjin Beichen Hospital, Tianjin, China., Xu J; Department of General Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, P.R. China., Liu Y; Department of Gastroenterology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, China., Ji L; Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, P.R. China., Zhang S; Department of Pathology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, P.R. China. zhangshiwu666@aliyun.com.
Source: Molecular cancer [Mol Cancer] 2026 Apr 10; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4598
DOI:10.1186/s12943-026-02659-w